QI
QS Investors Portfolio holdings
AUM $8.47B
1-Year Return
30.71%
This Quarter Return
+10.89%
1 Year Return
+30.71%
3 Year Return
+50.49%
5 Year Return
+87.52%
10 Year Return
–
AUM
$8.32B
AUM Growth
+$845M
(+11%)
Cap. Flow
+$179M
Cap. Flow
% of AUM
2.15%
Top 10 Holdings %
Top 10 Hldgs %
44.48%
Holding
1,295
New
131
Increased
333
Reduced
382
Closed
118
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$141M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$105M |
| 3 |
Vanguard Total Bond Market
BND
|
+$104M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$39.7M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$32.2M |
Top Sells
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$242M |
| 2 |
Duke Energy
DUK
|
+$16.4M |
| 3 |
SPDR Bloomberg Convertible Securities ETF
CWB
|
+$11.9M |
| 4 |
Evergy
EVRG
|
+$11.2M |
| 5 |
Gilead Sciences
GILD
|
+$11.2M |
Sector Composition
| 1 | Technology | 8.37% |
| 2 | Healthcare | 6.73% |
| 3 | Consumer Staples | 4.89% |
| 4 | Financials | 4.39% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Zynex
ZYXI
$45.4M
| $331K | ﹤0.01% |
+27,060
| New | +$331K |
|
|
HT
952
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $329K | ﹤0.01% |
41,700
+23,399
| +128% | +$185K |
|
953
Genesco
GCO
$373M
| $328K | ﹤0.01% |
10,900
| – | – |
|
954
Qiagen
QGEN
$9.85B
| $328K | ﹤0.01% |
5,858
+543
| +10% | +$30.4K |
|
955
Stanley Black & Decker
SWK
$12.1B
| $328K | ﹤0.01% |
1,838
+1
| +0.1% | +$178 |
|
|
WW
956
DELISTED
WW International
WW
| $328K | ﹤0.01% |
13,450
| – | – |
|
957
Lumen
LUMN
$5.74B
| $327K | ﹤0.01% |
33,493
+2,113
| +7% | +$20.6K |
|
958
RAPT Therapeutics
RAPT
$298M
| $324K | ﹤0.01% |
+2,050
| New | +$324K |
|
959
Tanger
SKT
$3.84B
| $324K | ﹤0.01% |
32,500
-6,100
| -16% | -$60.8K |
|
960
Casey's General Stores
CASY
$20.6B
| $323K | ﹤0.01% |
1,809
-810
| -31% | -$145K |
|
961
CyberArk
CYBR
$24.2B
| $322K | ﹤0.01% |
1,992
-15,666
| -89% | -$2.53M |
|
962
Orthofix Medical
OFIX
$590M
| $322K | ﹤0.01% |
7,500
-4,100
| -35% | -$176K |
|
963
Amphastar Pharmaceuticals
AMPH
$1.25B
| $320K | ﹤0.01% |
15,900
-4,900
| -24% | -$98.6K |
|
964
AnaptysBio
ANAB
$554M
| $320K | ﹤0.01% |
+14,900
| New | +$320K |
|
965
Cushman & Wakefield
CWK
$3.85B
| $320K | ﹤0.01% |
21,602
-698
| -3% | -$10.3K |
|
|
CNH
966
CNH Industrial
CNH
$13.6B
| $320K | ﹤0.01% |
28,646
| – | – |
|
|
TPC
967
Tutor Perini Corporation
TPC
$3.36B
| $320K | ﹤0.01% |
24,700
| – | – |
|
968
VF Corp
VFC
$5.77B
| $318K | ﹤0.01% |
3,722
| – | – |
|
|
CBAY
969
DELISTED
Cymabay Therapeutics
CBAY
| $317K | ﹤0.01% |
+55,200
| New | +$317K |
|
|
HOME
970
DELISTED
At Home Group Inc.
HOME
| $317K | ﹤0.01% |
+20,500
| New | +$317K |
|
971
Ligand Pharmaceuticals
LGND
$3.22B
| $316K | ﹤0.01% |
5,090
| – | – |
|
972
Henry Schein
HSIC
$8.17B
| $315K | ﹤0.01% |
4,705
+335
| +8% | +$22.4K |
|
973
Cyclerion Therapeutics
CYCN
$7.46M
| $314K | ﹤0.01% |
+5,130
| New | +$314K |
|
974
Willis Towers Watson
WTW
$32.4B
| $313K | ﹤0.01% |
1,488
| – | – |
|
|
RPT
975
Rithm Property Trust Inc.
RPT
$119M
| $313K | ﹤0.01% |
29,897
| – | – |
|